2014, Number 1
<< Back Next >>
Rev Mex Angiol 2014; 42 (1)
Tratamiento endovenoso de la enfermedad venosa crónica con láser 980nm y 1470nm. Resultados a seis años
Vásquez-Hernández M, Juárez-Becerra J, Estrada-Guerrero JG, López-García FR, González-Medellín LR, De los Santos-Mireles D
Language: Spanish
References: 23
Page: 21-27
PDF size: 271.03 Kb.
ABSTRACT
Introduction. The intravenous laser ablation or escisión is a frquently use treatment for the varicose
veins of the lower extremities, is of minimum invasión, effective, ando f minor complications.
Material and methods. We performed a transversal study from 2006 to 2012, evaluating patients
with chronic venous disease using the CEAP classificaction, incluiding the laser intravenous treatment
(EVLT) with a wave length 980nm and 1470nm with radial and bare fibers. Excluiding patients with
previous stripping or safenectomy. Follow-up was done with ultrasound every three months.
Results. They were 558 patients with chronic venous disease (462 female and 96 male) range of age 28
and 72 years, 55.3 average, excluding 54 patients with pevious safenectomy. From March 2006 to
October 2009 we utilized a length of wave 980nm and 12 watts with bare fiber in 216 patients (173 female
and 43 male) and 252 extremities (36 both sides). From August 2009 to December of 2012 we utilized
length of wave 1470nm and 5 watts average with radial fiber in 288 patients (242 female and 46
male) in 335 extremities (47 both sides). Classification of CEAP 2 for 980nm were 17 and 1470nm 26,
CEAP 3 (108 and 134), CEAP 4 (94 and 117), CEAP 5 (20 and 34), CEAP 6 (13 and 24) respectly.
Complications to 30 days for EVLT of 980nm were 95 (37.6%), fibrotic cord 39, pain minor to mild
20, paresthesis 15, equimosis 13, phlebitis 4, hematoma 3, thrombosis 1, burn 1, for 1470nm were 36
patients (10.7%) 6, 19, 5, 3, 3, 0, 0, respectly.
Conclusion. The intravenous laser treatment of the chronic venous disease is a reliable method, the
patients treated with length of wave 1470nm with radial fiber showing less incidence of complications.
REFERENCES
Anastasio B, Celebrier A, Cohen-Solal, Anido R, Bone C, Mordon S, Voung PN. Endovenous Iaser. Phlebologie 2003; 56(4): 369-82.
Ho P, Poon JT, Cho SY, Cheung G, Tam YF, Yeung WK, Cheng SW. Day surgery varicose treatment using endovenous laser. Hong Kong Med J 2009; 15(1): 39-43.
Hoggan Bl, Cameron AL, Maderrn GJ. Systemic review of endovenous laser therapy versus surgery for the treatment of saphenous varicose veins. Ann Vasc Surg 2009; 23: 277-87.
Puglisi B, Mazza A, San Filipo F. ND-YAg laser and argon laser for the radical and cosmetical treatment of the varicose syndrome XIe Congres Mondial Union Internationale de Phlebologie. Montreal 30/08-04/09. 1992.
Bone Salat C. Tratamiento endoluminal de las várices con láser de diodo. Estudio preliminar. Revista Patología Vascular 1999; V(1):31-9.
Navarro L, Min RJ, Bone C. Endovenous laser: a new minimally invasive method of treatment for varicose veins-preliminar observations using a 810 nm diode laser. Dermatol Surg 2001; 27(2): 117-22.
Desmyttrère. Endovenous laser ablation (980nm) of the small saphenous vein in a series of 147 limbs with a 3-year follow-up. Eur J Vasc Endovasc Surg 2010; 39(1): 99-103.
Park SW. Endovenous laser ablation of the incompetent small saphenous vein with a 982-nm diode laser: our experience with 3 years follow-up. Eur J Vasc Endovasc Surg 2008; 36(6): 738-42.
Pannier F. Mid-term results following endovenous laser ablation (EVLA) of saphenous veins with a 980nm diode laser. Int Angiol 2008; 27(6): 475-81.
Passman MA. Validation of Venous Clinical Severity Score (VCSS) with other venous severity assessment tools from the American Venous Forum, National Venous Screening Program. J Vasc Surg 2001; 54(6 Suppl.): 2S-9S.
Vázquez MA. Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American Venous Forum ad hoc Outcomes Working Group. J Vasc Surg 2010; 52(5): 1397-96.
Vuylsteke M. Endovenous laser treatment: is there a clinical difference between using a 1500nm and a 980nm diode laser? A multicenter randomized clinical trial. Int Angiol 2011; 30(4): 327-34.
Doganci S. Comparision of 980nm laser and bare-tip fiber with 1470nm laser and radial fiber in the treatment of great saphenous vein varicosities: a prospective randomized clinical trial. Eur J Vasc Endovasc Surg 2010; 40(2): 254-9.
Shepherd AC. Randomized clinical trial of VNUS Closure FAST radiofrequency ablation versus laser for varicose veins. Br J Surg 2010; 97(6): 810-8.
Rasmussen LH. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Br J Surg 2011; 98(8): 1079-87.
Dzieciuchowicz L. A prospective comparison of four methods of endovenous thermal ablation. Pol Przegl Chir 2011; 83(11): 597-605.
Chan CY. Retrospective comparision of clinical outcomes between endovenous laser and saphenous vein-sparing surgery for treatment of varicose veins. World J Surg 2011: 35(7): 1679-86.
Christenson JT. Prospective randomized trial comparing endovenous laser ablation and surgery for treatment of primary great saphenous varicose veins with a 2-year follow- up. J Vasc Surg 2010; 52(5): 1234-41.
Gloviczki P. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011; 53(5 Suppl.): 2S-48S.
Schwarz T. Endovenous laser ablation of varicose veins with the 1470-nm diode laser. J Vasc Surg 2010; 51(6): 1474-8.
Rathod J. Outcomes using a 1470-nm laser for symptomatic varicose veins. J Vasc Interv Radiol 2010; 21(12):1835-40.
Shepherd AC. Pain following 980-nm endovenous laser ablation and segmental radiofrequency ablation for varicose veins: a prospective observational study. Vasc Endovascular Surg 2010; 44(3): 212.
Doganci S, Demirkilic U. Comparision of 980 nm laser and Bare-tip fibre with 1470 nm laser and radial fiber in the treatment of great saphenous vein varicosities: a prospective randomized clinical trial. Eur J Vasc Endovasc Surg 2010; 40(2): 254-9.